Authors: Alarslan P, Doruk M.
DOI: 10.3389/fendo.2025.1682910
Abstract Summary
Chromogranin A (CgA), a neuroendocrine protein, shows promise as a novel biomarker for PCOS. This study found significantly elevated serum CgA levels in 75 PCOS patients versus controls (935 vs. 642 pg/mL). Higher CgA correlated independently with obesity, insulin resistance, and inflammation—key metabolic risk factors in PCOS. These findings suggest CgA could help stratify metabolic risk in PCOS patients.
Why Brain? ðŸ§
Chromogranin A levels are significantly elevated in PCOS patients and independently linked to obesity, insulin resistance, and inflammation, suggesting potential as a novel biomarker for metabolic risk assessment.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
